Cargando…

Risk Factors for Long-Term Vancomycin-Resistant Enterococci Persistence—A Prospective Longitudinal Study

Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens that require effective infection control measures, representing a challenge for healthcare systems. This study aimed at identifying risk factors associated with prolonged VRE carriage and determining the rate of clearance that...

Descripción completa

Detalles Bibliográficos
Autores principales: Correa-Martinez, Carlos L., Stollenwerk, Verena B., Kossow, Annelene, Schaumburg, Frieder, Mellmann, Alexander, Kampmeier, Stefanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843193/
https://www.ncbi.nlm.nih.gov/pubmed/31561632
http://dx.doi.org/10.3390/microorganisms7100400
_version_ 1783468157084631040
author Correa-Martinez, Carlos L.
Stollenwerk, Verena B.
Kossow, Annelene
Schaumburg, Frieder
Mellmann, Alexander
Kampmeier, Stefanie
author_facet Correa-Martinez, Carlos L.
Stollenwerk, Verena B.
Kossow, Annelene
Schaumburg, Frieder
Mellmann, Alexander
Kampmeier, Stefanie
author_sort Correa-Martinez, Carlos L.
collection PubMed
description Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens that require effective infection control measures, representing a challenge for healthcare systems. This study aimed at identifying risk factors associated with prolonged VRE carriage and determining the rate of clearance that allows the discontinuation of contact precautions. During a 2-year study, screening was performed in patients with a history of VRE or at risk of becoming colonized. After bacterial identification and antibiotic susceptibility testing, glycopeptide resistance was confirmed by PCR. Isolates were compared via whole genome sequence-based typing. Risk factors were recorded, and follow-up screening was performed upon readmission, defining patients as long-term carriers if still colonized ≥10 weeks after first detection. Of 1059 patients positive for VRE, carriage status was assessed upon readmission in 463 patients. VRE was cleared in 56.4% of the cases. Risk factors associated with long-term persistence were hospital stays (frequency, length), hemato-oncological disease, systemic treatment with steroids, and use of antibiotics. No specific genotypic clustering was observed in patients with VRE clearance or persistence. VRE clearance is possibly underestimated. The identification of risk factors favoring long-term carriage may contribute to a targeted implementation of infection control measures upon readmission of patients with history of VRE.
format Online
Article
Text
id pubmed-6843193
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68431932019-11-25 Risk Factors for Long-Term Vancomycin-Resistant Enterococci Persistence—A Prospective Longitudinal Study Correa-Martinez, Carlos L. Stollenwerk, Verena B. Kossow, Annelene Schaumburg, Frieder Mellmann, Alexander Kampmeier, Stefanie Microorganisms Article Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens that require effective infection control measures, representing a challenge for healthcare systems. This study aimed at identifying risk factors associated with prolonged VRE carriage and determining the rate of clearance that allows the discontinuation of contact precautions. During a 2-year study, screening was performed in patients with a history of VRE or at risk of becoming colonized. After bacterial identification and antibiotic susceptibility testing, glycopeptide resistance was confirmed by PCR. Isolates were compared via whole genome sequence-based typing. Risk factors were recorded, and follow-up screening was performed upon readmission, defining patients as long-term carriers if still colonized ≥10 weeks after first detection. Of 1059 patients positive for VRE, carriage status was assessed upon readmission in 463 patients. VRE was cleared in 56.4% of the cases. Risk factors associated with long-term persistence were hospital stays (frequency, length), hemato-oncological disease, systemic treatment with steroids, and use of antibiotics. No specific genotypic clustering was observed in patients with VRE clearance or persistence. VRE clearance is possibly underestimated. The identification of risk factors favoring long-term carriage may contribute to a targeted implementation of infection control measures upon readmission of patients with history of VRE. MDPI 2019-09-26 /pmc/articles/PMC6843193/ /pubmed/31561632 http://dx.doi.org/10.3390/microorganisms7100400 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Correa-Martinez, Carlos L.
Stollenwerk, Verena B.
Kossow, Annelene
Schaumburg, Frieder
Mellmann, Alexander
Kampmeier, Stefanie
Risk Factors for Long-Term Vancomycin-Resistant Enterococci Persistence—A Prospective Longitudinal Study
title Risk Factors for Long-Term Vancomycin-Resistant Enterococci Persistence—A Prospective Longitudinal Study
title_full Risk Factors for Long-Term Vancomycin-Resistant Enterococci Persistence—A Prospective Longitudinal Study
title_fullStr Risk Factors for Long-Term Vancomycin-Resistant Enterococci Persistence—A Prospective Longitudinal Study
title_full_unstemmed Risk Factors for Long-Term Vancomycin-Resistant Enterococci Persistence—A Prospective Longitudinal Study
title_short Risk Factors for Long-Term Vancomycin-Resistant Enterococci Persistence—A Prospective Longitudinal Study
title_sort risk factors for long-term vancomycin-resistant enterococci persistence—a prospective longitudinal study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843193/
https://www.ncbi.nlm.nih.gov/pubmed/31561632
http://dx.doi.org/10.3390/microorganisms7100400
work_keys_str_mv AT correamartinezcarlosl riskfactorsforlongtermvancomycinresistantenterococcipersistenceaprospectivelongitudinalstudy
AT stollenwerkverenab riskfactorsforlongtermvancomycinresistantenterococcipersistenceaprospectivelongitudinalstudy
AT kossowannelene riskfactorsforlongtermvancomycinresistantenterococcipersistenceaprospectivelongitudinalstudy
AT schaumburgfrieder riskfactorsforlongtermvancomycinresistantenterococcipersistenceaprospectivelongitudinalstudy
AT mellmannalexander riskfactorsforlongtermvancomycinresistantenterococcipersistenceaprospectivelongitudinalstudy
AT kampmeierstefanie riskfactorsforlongtermvancomycinresistantenterococcipersistenceaprospectivelongitudinalstudy